HTFL|Heartflow Inc|Price:27.740|Chg%:1.75

More Details of Heartflow Inc Company

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc Info



Ticker SymbolHTFL

Company nameHeartflow Inc

IPO dateAug 08, 2025

CEOFarquhar (John C. M)

Number of employees699

Security typeOrdinary Share

Fiscal year-endAug 08

Address331 E Evelyn Avenue

CityMOUNTAIN VIEW

Stock exchangeNASDAQ OMX - NASDAQ BASIC

CountryUnited States of America

Postal code94041

Phone16502411221

Websitehttps://www.heartflow.com/

Ticker SymbolHTFL

IPO dateAug 08, 2025

CEOFarquhar (John C. M)

Company Executives of Heartflow Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Vikram Verghese

Chief Financial Officer

123.86K

-471.00%

Mr. Jeffrey C. Lightcap

Independent Director

40.00K

+40000.00%

Mr. Lonnie M. Smith

Independent Director

34.25K

+34246.00%

Mr. Casey M. Tansey

Independent Director

16.45K

+16447.00%

Dr. Charles A. Taylor, Ph.D.

Director

--

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

--

Mr. John C. M. Farquhar

President, Chief Executive Officer, Director

--

Ms. Julie Cullivan

Independent Director

--

Mr. Tim Barabe

Independent Director

--

Dr. Wayne Riley, M.D.

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Vikram Verghese

Chief Financial Officer

123.86K

-471.00%

Mr. Jeffrey C. Lightcap

Independent Director

40.00K

+40000.00%

Mr. Lonnie M. Smith

Independent Director

34.25K

+34246.00%

Mr. Casey M. Tansey

Independent Director

16.45K

+16447.00%

Dr. Charles A. Taylor, Ph.D.

Director

--

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6

FY2025Q3

Relevant data have not been disclosed by the company yet.

By RegionUSD

Name

Revenue

Proportion

United states

42.95M

92.80%

United kingdom

1.52M

3.28%

Japan

1.46M

3.16%

Rest of europe

349.00K

0.75%

By Business

By Region

Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Tue, Feb 3

Shareholders

Shareholder Types

Shareholders

Proportion

Bain Capital Life Sciences Investors, LLC

14.62%

HealthCor Partners Management LP

7.86%

Wellington Management Company, LLP

5.73%

Fidelity Management & Research Company LLC

5.42%

Capricorn Investment Group LLC

4.61%

Other

61.76%

Shareholders

Proportion

Bain Capital Life Sciences Investors, LLC

14.62%

HealthCor Partners Management LP

7.86%

Wellington Management Company, LLP

5.73%

Fidelity Management & Research Company LLC

5.42%

Capricorn Investment Group LLC

4.61%

Other

61.76%

Shareholder Types

Shareholders

Proportion

Investment Advisor

53.98%

Investment Advisor/Hedge Fund

12.51%

Hedge Fund

3.17%

Individual Investor

2.47%

Endowment Fund

0.37%

Bank and Trust

0.32%

Private Equity

0.18%

Pension Fund

0.14%

Research Firm

0.10%

Other

26.77%

Institutional Shareholding



Updated: Wed, Jan 21

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2026Q4

129

59.51M

43.48%

--

2025Q4

149

60.27M

70.78%

+21.99M

2025Q3

46

45.42M

54.46%

+42.91M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

Bain Capital Life Sciences Investors, LLC

12.45M

14.62%

--

Sep 30, 2025

HealthCor Partners Management LP

6.70M

7.86%

--

Sep 30, 2025

Wellington Management Company, LLP

4.88M

5.73%

+465.57K

+10.55%

Sep 30, 2025

Fidelity Management & Research Company LLC

4.62M

5.42%

+1.33M

+40.42%

Sep 30, 2025

Capricorn Investment Group LLC

3.92M

4.61%

+3.92M

--

Aug 08, 2025

Hayfin Capital Management LLP

3.64M

4.27%

-1.00

-0.00%

Sep 30, 2025

Baillie Gifford & Co.

3.01M

3.53%

+415.89K

+16.06%

Sep 30, 2025

Schusterman Interests LLC

1.94M

2.28%

+1.94M

--

Sep 30, 2025

The Vanguard Group, Inc.

1.45M

1.7%

+285.27K

+24.45%

Sep 30, 2025

Capital International Investors

1.30M

1.52%

+1.30M

--

Sep 30, 2025

Related ETFs



Updated: Sat, Dec 6

Name

Proportion

TrueShares Technology, AI & Deep Learning ETF

3.13%

Global X HealthTech ETF

1.75%

Fidelity Blue Chip Growth ETF

0.07%

T Rowe Price Small-Mid Cap ETF

0.06%

iShares Health Innovation Active ETF

0.02%

Schwab U.S. Small-Cap ETF

0.02%

Fidelity Nasdaq Composite Index ETF

0.01%

Schwab U.S. Broad Market ETF

0%

TrueShares Technology, AI & Deep Learning ETF

Proportion3.13%

Global X HealthTech ETF

Proportion1.75%

Fidelity Blue Chip Growth ETF

Proportion0.07%

T Rowe Price Small-Mid Cap ETF

Proportion0.06%

iShares Health Innovation Active ETF

Proportion0.02%

Schwab U.S. Small-Cap ETF

Proportion0.02%

Fidelity Nasdaq Composite Index ETF

Proportion0.01%

Schwab U.S. Broad Market ETF

Proportion0%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Splits



Date

Ex-dividend Date

Type

Ratio

No Data

Date

Ex-dividend Date

Type

Ratio

No Data